SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Latigo Biotherapeutics Names Todd N. Smith CEO; Farzan to Advise Through 2027

Todd N. Smith succeeds Nima Farzan as CEO. Farzan will remain a strategic advisor through 2027.

LTGO

Related stories